(Q77556842)
Statements
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity (English)
Meropol NJ
Porter M
Blumenson LE
Lindemann MJ
Perez RP
Vaickus L
Loewen GM
Creaven PJ
Wilkes KA
Giedlin MA